Literature DB >> 23988701

Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1.

Yang Xia1, Qiyou Chen, Zhaopeng Zhong, Caihua Xu, Chen Wu, Bin Liu, Yijiang Chen.   

Abstract

BACKGROUND: The connection between microRNA expression and lung cancer development has been identified in recent literature. However, the mechanism of microRNA has been poorly elucidated in non-small-cell lung cancer (NSCLC). METHODS AND
RESULTS: Comparing with adjacent tissues (n=75), miR-30c has a lower expression in lung cancer specimens (n=75). The knockdown of miR-30c enhanced the invasion of A549 cells; meanwhile, the overexpression of miR-30c could reverse the effect of the knockdown of miR-30c in vitro. A luciferase assay revealed that miR-30c was directly bound to the 3'-untranslated regions (3'-UTR) of MTA1. QRT-PCR and western blot shows MTA1 was up-regulated in mRNA and protein levels. The effect taken on the invasion of NSCLC by overexpression of MTA1 works the same as down-regulated miR-30c.
CONCLUSION: miR-30c may play a pivotal role in controlling lung cancer invasion through regulating MTA1in NSCLC.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23988701     DOI: 10.1159/000354452

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  19 in total

1.  MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.

Authors:  L Deng; J Tang; H Yang; C Cheng; S Lu; R Jiang; B Sun
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

Review 2.  Post-transcriptional regulation of MTA family by microRNAs in the context of cancer.

Authors:  Yun Zhang; Xiao-Fan Wang
Journal:  Cancer Metastasis Rev       Date:  2014-12       Impact factor: 9.264

3.  Inhibition of the growth of non-small cell lung cancer by miRNA-1271.

Authors:  Zhen Zhou; Xiaoming Niu; Chuanjia Li; Shengping Sheng; Shun Lu
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells.

Authors:  Koichiro Tsukasa; Qiang Ding; Yumi Miyazaki; Shyuichiro Matsubara; Shoji Natsugoe; Sonshin Takao
Journal:  Hum Cell       Date:  2016-03-10       Impact factor: 4.174

5.  Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

Authors:  Bei Pei; Tongyang Li; Qi Qian; Wenqiang Fan; Xiao He; Yulan Zhu; Lingyun Xu
Journal:  Gland Surg       Date:  2020-06

6.  The role of microRNA-30c in targeting interleukin 6, as an inflammatory cytokine, in the mesenchymal stem cell: a therapeutic approach in colorectal cancer.

Authors:  Mohamad Mahjoor; Hamed Afkhami; Mohammad Najafi; Atieh Nasr; Samaneh Khorrami
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-25       Impact factor: 4.322

7.  MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.

Authors:  Heying Chu; Xudong Chen; Huaqi Wang; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Ping Li; Juan Li; Jingxia Chang; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-11-29

Review 8.  Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.

Authors:  Junli Xue; Victoria K Xie; Peipei Wang; Jiujie Cui; Yong Gao; Zhimin Lu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2.

Authors:  Ling Yu Zhao; Yu Yao; Jia Han; Juan Yang; Xiao Fei Wang; Dong Dong Tong; Tu Sheng Song; Chen Huang; Yuan Shao
Journal:  Dig Dis Sci       Date:  2014-03-13       Impact factor: 3.199

10.  MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.

Authors:  Lauren MacDonagh; Michael F Gallagher; Brendan Ffrench; Claudia Gasch; Steven G Gray; Marie Reidy; Siobhan Nicholson; Niamh Leonard; Ronan Ryan; Vincent Young; John J O'Leary; Sinead Cuffe; Stephen P Finn; Kenneth J O'Byrne; Martin P Barr
Journal:  Transl Lung Cancer Res       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.